drugset / Trial / NCT01527903

A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit

NCT01527903 ↗

Phase 4 Completed 77 enrolled Yonsei University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare propofol-remifentanil sedation with midazolam-remifentanil sedation in regards to extubation and weaning time, length of stay in the ICU, as well as the incidence of delirium. Primary end-points were weaning time and extubation time, and secondary end-points were the incidence of delirium and length of stay in the ICU.

Timeline

Start
2009-09
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 0.1 mg/kg —
Comparator Propofol Small molecule 1 mg/kg Intravenous

Indications

No indication recorded.